Seagen, Genmab's Tivdak improves survival for cervical cancer patients in phase 3 trial
5th September 2023 Uncategorised 0 Seagen, Genmab’s Tivdak improves survival for cervical cancer patients in phase 3 trial
zbecker
Tue, 09/05/2023 – 10:40
More: Seagen, Genmab's Tivdak improves survival for cervical cancer patients in phase 3 trial
Source: fierce
